MedPath

Effectiveness, Stability and Influence Factors of Femtosecond Laser Assisted Cataract Surgery

Recruiting
Conditions
Corneal Astigmatism
Cataract
Registration Number
NCT07081919
Lead Sponsor
Eye & ENT Hospital of Fudan University
Brief Summary

What is this study about? This study looks at whether a laser procedure called femtosecond laser-assisted arcuate keratotomy (FSAK) helps people with both cataracts and mild astigmatism see more clearly after cataract surgery. Astigmatism causes blurry vision because the front of the eye (cornea) is curved unevenly. The FSAK procedure uses a computer-guided laser to make tiny, precise cuts in the cornea during cataract surgery to fix this curve. the investigators want to see if this improves vision long-term (up to 5 years) and what factors affect how the investigatorsll it works.

Who can join? the investigators are looking for adults aged 20-80 years who:

Have cataracts and mild-to-moderate astigmatism (0.75-2.0 diopters) Plan to have cataract surgery Have not had prior eye surgeries (like LASIK) Do not have severe dry eye or other eye diseases (like glaucoma or retina problems) What will happen in the study?

Surgery: Participants will have cataract surgery combined with the FSAK procedure. The surgeon uses a laser to make tiny curved cuts in the cornea to reshape it.

Follow-up visits: Participants will have regular eye check-ups for 5 years after surgery. These include:

Vision tests (reading eye charts) Measurements of the eye's shape using painless imaging machines Questionnaires about vision quality and daily activities Time commitment: Visits happen at 1 the investigatorsek, 1 month, 3 months, 6 months, 1 year, 2 years, and 5 years after surgery. Each visit takes about 1-2 hours.

Why is this study important? FSAK may help people with astigmatism see clearly after cataract surgery without needing glasses as often. By tracking results for 5 years, the investigators'll learn how long the benefits last and who benefits most. This could help doctors better personalize treatment in the future.

Who is running the study? Eye doctors at Fudan University Eye \& ENT Hospital (Shanghai) and Shanghai Peace Eye Hospital. About 105 people will take part.

Detailed Description

Study Description for General Audience

What's the problem? Many people with cataracts also have an irregularly curved front surface of the eye (called astigmatism). After cataract surgery, this astigmatism can still cause blurry or distorted vision, making everyday tasks like reading or driving difficult. While glasses or special lenses can help, many hope to reduce their dependence on them after surgery.

What's being tested?

This study evaluates a laser procedure called Femtosecond Laser-Assisted Arcuate Keratotomy (FSAK). During cataract surgery:

A computer-guided laser makes tiny, curved incisions in the cornea (the eye's clear front window).

These precise incisions gently reshape the cornea to improve its natural curve. Think of it like a sculptor smoothing uneven surfaces-but using light-speed technology.

Why is this study unique?

While FSAK isn't brand new, the investigators lack long-term data on:

How the investigatorsll it holds up over 5+ years. Which factors predict success (e.g., does participantsr eye's shape or pressure affect results?).

the investigators're following participants for 5 years to ansthe investigatorsr these questions-far longer than most existing studies.

What will participants experience?

Surgery: FSAK is combined with standard cataract removal. The laser step adds only minutes.

Follow-ups: Painless check-ups at 1 the investigatorsek, 1 month, 3 months, 6 months, 1 year, 2 years, and 5 years after surgery. These involve:

Reading eye charts. Quick scans to map the eye's surface. Short questionnaires about vision quality (e.g., glare at night or reading small print).

Why does this matter?

If successful, FSAK could:

* Help people see clearly longer after cataract surgery.

* Reduce the need for glasses or contacts.

* Give doctors better tools to personalize treatment.

Who's involved?

Led by eye specialists at Fudan University Eye \& ENT Hospital and Shanghai Peace Eye Hospital.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
105
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in corneal astigmatism magnitude (diopters) from baselinePreoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively
Secondary Outcome Measures
NameTimeMethod
Patient-Reported OutcomesPreoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

bjective visual quality can be assessed with the Visual Function-14 (VF-14) questionnaire, which evaluates 14 vision-dependent daily activities. Patients self-rate their functional limitations, with scores ranging from 0 (worst) to 100 (best), where higher scores indicate better visual function. It is administered preoperatively and 3 months postoperatively to measure changes, with a minimal clinically important difference of 15.57, meaning a score change exceeding this value signifies a meaningful improvement The DOI of reference for visual function questionnaire is 10.1016/j.ophtha.2010.04.009.

Visual Acuity-UCVAPreoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

Uncorrected Distance Visual Acuity (UDVA) at 5m (logMAR)

Corneal TopographyPreoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

Corneal Topography assesses corneal curvature, with data collected using the Pentacam instrument and IOL Master. The measured outcome reflects the corneal's refractive power and shape characteristics. Corneal curvature is reported in diopters (D) , a standard unit for quantifying refractive power in ophthalmic measurements.

Visual acuity-BCVAPreoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

Best-Corrected Visual Acuity (BCVA) at 5m (logMAR)

Objective Optical QualityPreoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

Objective visual quality is evaluated by measuring Total ocular higher - order aberrations (HOAs, unit: µm) and Strehl ratio (SR) using the iTrace instrument. Total ocular higher - order aberrations reflect the deviation of the eye's optical system from an ideal state, where higher values generally indicate greater optical imperfections that may disrupt visual clarity. The Strehl ratio, on the other hand, quantifies the quality of optical imaging; a higher SR (ranging from 0 to 1, with 1 representing ideal optical quality) signifies better visual quality, as it relates to the concentration of light in the retinal image. These metrics, derived from iTrace measurements, provide objective assessments of how well the eye processes visual input, crucial for evaluating surgical outcomes (e.g., cataract or refractive surgery) and ocular health.

Manifest refraction spherical equivalent (MRSE) in Diopter (D)Preoperative; 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively

Trial Locations

Locations (1)

Eye and Ear, Nose, and Throat Hospital of Fudan University

🇨🇳

Shanghai, Shanghai, China

Eye and Ear, Nose, and Throat Hospital of Fudan University
🇨🇳Shanghai, Shanghai, China
Jin Yang, PhD
Contact
13671632525
jin_er76@hotmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.